Author:
Dent Paul,Booth Laurence,Poklepovic Andrew,Hoff Daniel Von,Hancock John F.
Funder
Massey Cancer Center and the Universal Inc.
Commonwealth Health Research Board
Reference27 articles.
1. Dent P. HDAC inhibitors enhance neratinib activity and when combined enhance the actions of an anti-PD-1 immunomodulatory antibody in vivo;Booth;Oncotarget,2017
2. Neratinib augments the lethality of [regorafenib+sildenafil];Booth;J. Cell. Physiol.,2019
3. [Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration;Booth;Oncotarget.,2017
4. Neratinib and Entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Gαq and Gα11 and kill uveal melanoma cells;Booth;Cancer Biol. Ther.,2018
5. The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib;Booth;Semin. Cancer Biol.,2019
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献